Clinical Trials Logo

Clinical Trial Summary

A dose-escalation study to assess the safety, tolerability and clinical activity of TD-1211 in patients with opioid-induced constipation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01333540
Study type Interventional
Source Theravance Biopharma
Contact
Status Completed
Phase Phase 2
Start date May 2011
Completion date June 2012

See also
  Status Clinical Trial Phase
Completed NCT01309841 - Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation Phase 3
Completed NCT01323790 - Assessment of Efficacy and Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation Phase 3
Completed NCT01395524 - A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation Phase 3
Recruiting NCT05588323 - Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids Phase 1/Phase 2
Completed NCT01336205 - Assessment of Long-term Safety in Patients With Non-cancer-related Pain and Opioid-induced Constipation Phase 3